Arkolith/Insider Trading/WST/Form 4

Winters Chad

VP, Chief Accounting OfficerWEST PHARMACEUTICAL SERVICES INC (WST) · full profile →Form 4 · filed Apr 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$269K
Net Open-Market Flow
-$269K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2026Option exercise(M)896$173.22$155K2K
Apr 27, 2026Sell(S)896$300.67$269K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2026Option exercise(M)896—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000105770-26-000053) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML